EUVIMEDEUVIMED entdecken
Crossref

Age of hepatitis B e antigen loss in Aboriginal, Torres Strait Islander and non-Indigenous residents of tropical Australia; implications for clinical care

Liana Neldner, Sharna Radlof, Simon Smith, Margaret Littlejohn, Allison Hempenstall, Josh Hanson

Communicable Diseases Intelligence · 2024

DOI: 10.33321/cdi.2024.48.48 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Communicable Diseases Intelligence, 2024. Verfasst von Liana Neldner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Cairns Hospital, Cairns, Queensland, Australia. Hauptthemen laut MEDLINE: Hepatitis B e Antigens, Hepatitis B virus, Hepatitis B, Chronic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study determined the hepatitis B e antigen (HBeAg) status of people living with chronic hepatitis B (CHB) in Far North Queensland (FNQ), Australia and their age of HBeAg loss. It was hoped that this would provide data to explain the stark difference in the incidence of hepatocellular carcinoma (HCC) between Aboriginal and Torres Strait Islander individuals living with CHB in FNQ, a finding that has been hypothesised to relate to differences in hepatitis B virus genotype. We identified every FNQ resident with CHB, determined their country of birth, their HBeAg status, the age they lost HBeAg and whether they identified as an Aboriginal, a Torres Strait Islander or a non-Indigenous individual. We then ascertained whether these demographic and virological variables were correlated. Of 1,474 individuals living with CHB in FNQ, 278 (19%) were Aboriginal, 507 (34%) were Torres Strait Islanders and 689 (47%) were non-Indigenous. Aboriginal individuals were less likely to be HBeAg positive (26/278, 9%) than Torres Strait Islander (91/507, 18%) and non-Indigenous (126/689, 18%) individuals, p < 0.0001. Aboriginal individuals lost HBeAg at an earlier age (median (interquartile range): 30 (23–39) years) than Torres Strait Islander (38 (29–49) years) and non-Indigenous (36 (29–47) years) individuals, p < 0.0001. Aboriginal individuals with CHB in FNQ are more likely to be HBeAg negative than Torres Strait Islander and non-Indigenous individuals and lose HBeAg at a younger age. This provides a biological basis for local clinicians’ observation that Aboriginal individuals with CHB in FNQ are at a lower risk of HCC and data to support the principle of genotype-based care in the region.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B e AntigensHepatitis B virusHepatitis B, ChronicAdultAgedFemaleHumansMaleMiddle AgedYoung AdultAustraliaAustralian Aboriginal and Torres Strait Islander PeoplesCarcinoma, HepatocellularGenotypeLiver NeoplasmsQueensland

Stichwörter der Autor:innen

HBeAgIndigenous healthhepatitis B genotypehepatitis B virushepatocellular carcinomarural and remote health

Substanzen

Hepatitis B e Antigens

Autor:innen und Institutionen

  • Department of Medicine, Cairns Hospital, Cairns, Queensland, Australia.
  • Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, Melbourne, Australia.
  • Department of Infectious Disease, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Public Health Unit, Torres and Cape Hospital and Health Service, Queensland, Australia.
  • College of Medicine and Dentistry, James Cook University, Queensland, Australia.
  • Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

Zitieren

APA

Neldner, L., Radlof, S., Smith, S., Littlejohn, M., Hempenstall, A., & Hanson, J. (2024). Age of hepatitis B e antigen loss in Aboriginal, Torres Strait Islander and non-Indigenous residents of tropical Australia; implications for clinical care. Communicable Diseases Intelligence. https://doi.org/10.33321/cdi.2024.48.48

Vancouver

Neldner L, Radlof S, Smith S, Littlejohn M, Hempenstall A, Hanson J. Age of hepatitis B e antigen loss in Aboriginal, Torres Strait Islander and non-Indigenous residents of tropical Australia; implications for clinical care. Communicable Diseases Intelligence. 2024. doi:10.33321/cdi.2024.48.48

BibTeX
@article{Neldner2024,
  author = {Neldner, Liana and Radlof, Sharna and Smith, Simon and Littlejohn, Margaret and Hempenstall, Allison and Hanson, Josh},
  title = {Age of hepatitis B e antigen loss in Aboriginal, Torres Strait Islander and non-Indigenous residents of tropical Australia; implications for clinical care},
  journal = {Communicable Diseases Intelligence},
  year = {2024},
  doi = {10.33321/cdi.2024.48.48}
}
Kostenlos starten →